• Something wrong with this record ?

Anti-inflammatory active gold(I) complexes involving 6-substituted-purine derivatives

Z. Trávníček, P. Starha, J. Vančo, T. Silha, J. Hošek, P. Suchý, G. Pražanová

. 2012 ; 55 (10) : 4568-4579.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

The gold(I) complexes of the general formula [Au(L(n))(PPh(3))]·xH(2)O (1-8; n = 1-8 and x = 0-1.5), where L(n) stands for a deprotonated form of the benzyl-substituted derivatives of 6-benzylaminopurine, were prepared, thoroughly characterized (elemental analyses, FT-IR, Raman and multinuclear NMR spectroscopy, ESI+ mass spectrometry, conductivity, DFT calculations), and studied for their in vitro cytotoxicity and in vitro and in vivo anti-inflammatory effects on LPS-activated macrophages (derived from THP-1 cell line) and using the carrageenan-induced hind paw edema model on rats. The obtained results indicate that the representative complexes (1, 3, 6) exhibit a strong ability to reduce the production of pro-inflammatory cytokines TNF-α, IL-1β and HMGB1 without influence on the secretion of anti-inflammatory cytokine IL-1RA in the LPS-activated macrophages. The complexes also significantly influence the formation of edema, caused by the intraplantar application of polysaccharide λ-carrageenan to rats in vivo. All the tested complexes showed similar or better biological effects as compared with Auranofin, but contrary to Auranofin they were found to be less cytotoxic in vitro. The obtained results clearly indicate that the gold(I) complexes behave as very effective anti-inflammatory agents and could prove to be useful for the treatment of difficult to treat inflammatory diseases such as rheumatoid arthritis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12034541
003      
CZ-PrNML
005      
20160818060559.0
007      
ta
008      
121023s2012 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/jm201416p $2 doi
035    __
$a (PubMed)22541000
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Trávníček, Zdeněk, $d 1964- $7 ola2004209199 $u Regional Centre of Advanced Technologies and Materials, Department of Inorganic Chemistry, Faculty of Science, Palacký University, 17 listopadu 1192/12, 771 46 Olomouc, Czech Republic. zdenek.travnicek@upol.cz
245    10
$a Anti-inflammatory active gold(I) complexes involving 6-substituted-purine derivatives / $c Z. Trávníček, P. Starha, J. Vančo, T. Silha, J. Hošek, P. Suchý, G. Pražanová
520    9_
$a The gold(I) complexes of the general formula [Au(L(n))(PPh(3))]·xH(2)O (1-8; n = 1-8 and x = 0-1.5), where L(n) stands for a deprotonated form of the benzyl-substituted derivatives of 6-benzylaminopurine, were prepared, thoroughly characterized (elemental analyses, FT-IR, Raman and multinuclear NMR spectroscopy, ESI+ mass spectrometry, conductivity, DFT calculations), and studied for their in vitro cytotoxicity and in vitro and in vivo anti-inflammatory effects on LPS-activated macrophages (derived from THP-1 cell line) and using the carrageenan-induced hind paw edema model on rats. The obtained results indicate that the representative complexes (1, 3, 6) exhibit a strong ability to reduce the production of pro-inflammatory cytokines TNF-α, IL-1β and HMGB1 without influence on the secretion of anti-inflammatory cytokine IL-1RA in the LPS-activated macrophages. The complexes also significantly influence the formation of edema, caused by the intraplantar application of polysaccharide λ-carrageenan to rats in vivo. All the tested complexes showed similar or better biological effects as compared with Auranofin, but contrary to Auranofin they were found to be less cytotoxic in vitro. The obtained results clearly indicate that the gold(I) complexes behave as very effective anti-inflammatory agents and could prove to be useful for the treatment of difficult to treat inflammatory diseases such as rheumatoid arthritis.
650    _2
$a zvířata $7 D000818
650    _2
$a antiflogistika nesteroidní $x chemická syntéza $x chemie $x farmakologie $7 D000894
650    _2
$a karagenan $7 D002351
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a komplexní sloučeniny $x chemická syntéza $x chemie $x farmakologie $7 D056831
650    _2
$a cytokiny $x krev $7 D016207
650    _2
$a cytotoxiny $x chemická syntéza $x chemie $x farmakologie $7 D003603
650    _2
$a edém $x chemicky indukované $x farmakoterapie $x metabolismus $x patologie $7 D004487
650    _2
$a zlato $7 D006046
650    _2
$a lidé $7 D006801
650    _2
$a akutní monocytární leukemie $7 D007948
650    _2
$a lipopolysacharidy $x farmakologie $7 D008070
650    _2
$a makrofágy $x účinky léků $x metabolismus $7 D008264
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a molekulární struktura $7 D015394
650    _2
$a puriny $x chemická syntéza $x chemie $x farmakologie $7 D011687
650    _2
$a kvantová teorie $7 D011789
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Štarha, Pavel $7 jo2013759532 $u Regional Centre of Advanced Technologies and Materials, Department of Inorganic Chemistry, Faculty of Science, Palacký University, 17 listopadu 1192/12, 771 46 Olomouc, Czech Republic
700    1_
$a Vančo, Ján $7 xx0105810 $u Regional Centre of Advanced Technologies and Materials, Department of Inorganic Chemistry, Faculty of Science, Palacký University, 17 listopadu 1192/12, 771 46 Olomouc, Czech Republic
700    1_
$a Šilha, Tomáš $7 xx0217842 $u Regional Centre of Advanced Technologies and Materials, Department of Inorganic Chemistry, Faculty of Science, Palacký University, 17 listopadu 1192/12, 771 46 Olomouc, Czech Republic
700    1_
$a Hošek, Jan $7 xx0106185 $u Regional Centre of Advanced Technologies and Materials, Department of Inorganic Chemistry, Faculty of Science, Palacký University, 17 listopadu 1192/12, 771 46 Olomouc, Czech Republic; Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1/3, 612 42 Brno, Czech Republic
700    1_
$a Suchý, Pavel, $d 1970- $7 mzk2008448769 $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1/3, 612 42 Brno, Czech Republic
700    1_
$a Pražanová, Gabriela $7 _AN069112 $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1/3, 612 42 Brno, Czech Republic
773    0_
$w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 55, č. 10 (2012), s. 4568-4579
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22541000 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20121023 $b ABA008
991    __
$a 20160818060852 $b ABA008
999    __
$a ok $b bmc $g 956551 $s 792038
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 55 $c 10 $d 4568-4579 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
LZP    __
$b NLK122 $a Pubmed-20121023

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...